Trial Profile
Randomised crossover trial to evaluate the effects of Zileuton in patients with Sjogren-Larsson syndrome assessing potential benefit in terms of symptoms (itch), biochemical and neuropsychological indices
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Zileuton (Primary)
- Indications Sjogren-Larsson syndrome
- Focus Therapeutic Use
- 29 Jun 2016 New trial record